Soon, many patients might initiate contact with the health system not by speaking with a call center worker or receptionist, ...

“djuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.

Our study highlights a concerning 3-fold increase in obesity-related cancer deaths since 1999,” said study author Faizan Ahmed, MD.